410 related articles for article (PubMed ID: 11221167)
1. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
Fadilah SA; Faridah I; Cheong SK
Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
[TBL] [Abstract][Full Text] [Related]
2. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
3. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Lim HL; Teo CP; Wong K; Kueh YK
Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
[TBL] [Abstract][Full Text] [Related]
4. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
6. Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Jörck C; Kiess W; Weigel JF; Mütze U; Bierbach U; Beblo S
Pediatr Hematol Oncol; 2011 Feb; 28(1):3-9. PubMed ID: 20615069
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function is not affected by second exposure to erwinia asparaginase for childhood acute lymphoblastic leukemia.
Bossi G; Larizza D; Conter V
Haematologica; 1997; 82(4):507-8. PubMed ID: 9299875
[No Abstract] [Full Text] [Related]
8. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
Tomar S; Bakhshi S; Kabra SK; Arya LS
Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
[No Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
[No Abstract] [Full Text] [Related]
10. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Wu SF; Chen AC; Peng CT; Wu KH
Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
[TBL] [Abstract][Full Text] [Related]
11. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
12. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
Skomra S; Przybylska T
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
[TBL] [Abstract][Full Text] [Related]
13. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
[TBL] [Abstract][Full Text] [Related]
14. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
Salvador C; Meister B; Crazzolara R; Kropshofer G
Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026
[No Abstract] [Full Text] [Related]
15. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
Bodmer M; Sulz M; Stadlmann S; Droll A; Terracciano L; Krähenbühl S
Digestion; 2006; 74(1):28-32. PubMed ID: 16988508
[TBL] [Abstract][Full Text] [Related]
16. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report.
Misgar RA; Laway BA; Rahaman SH; Wani AI; Bashir MI; Bhat JR
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):439-41. PubMed ID: 25210761
[TBL] [Abstract][Full Text] [Related]
17. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
19. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
